Cargando…

Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination

PURPOSE: We describe the impact of a multifaceted program for decreasing ventilator-associated pneumonia (VAP) after implementing nine preventive measures, including selective oropharyngeal decontamination (SOD). METHODS: We compared VAP rates during an 8-month pre-intervention period, a 12-month in...

Descripción completa

Detalles Bibliográficos
Autores principales: Landelle, C., Nocquet Boyer, V., Abbas, M., Genevois, E., Abidi, N., Naimo, S., Raulais, R., Bouchoud, L., Boroli, F., Terrisse, H., Bosson, J.-L., Harbarth, S., Pugin, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244525/
https://www.ncbi.nlm.nih.gov/pubmed/30343312
http://dx.doi.org/10.1007/s00134-018-5227-4
_version_ 1783372071049363456
author Landelle, C.
Nocquet Boyer, V.
Abbas, M.
Genevois, E.
Abidi, N.
Naimo, S.
Raulais, R.
Bouchoud, L.
Boroli, F.
Terrisse, H.
Bosson, J.-L.
Harbarth, S.
Pugin, J.
author_facet Landelle, C.
Nocquet Boyer, V.
Abbas, M.
Genevois, E.
Abidi, N.
Naimo, S.
Raulais, R.
Bouchoud, L.
Boroli, F.
Terrisse, H.
Bosson, J.-L.
Harbarth, S.
Pugin, J.
author_sort Landelle, C.
collection PubMed
description PURPOSE: We describe the impact of a multifaceted program for decreasing ventilator-associated pneumonia (VAP) after implementing nine preventive measures, including selective oropharyngeal decontamination (SOD). METHODS: We compared VAP rates during an 8-month pre-intervention period, a 12-month intervention period, and an 11-month post-intervention period in a cohort of patients who received mechanical ventilation (MV) for > 48 h. The primary objective was to assess the effect on first VAP occurrence, using a Cox cause-specific proportional hazards model. Secondary objectives included the impact on emergence of antimicrobial resistance, antibiotic consumption, duration of MV, and ICU mortality. RESULTS: Pre-intervention, intervention and post-intervention VAP rates were 24.0, 11.0 and 3.9 VAP episodes per 1000 ventilation-days, respectively. VAP rates decreased by 56% [hazard ratio (HR) 0.44, 95% CI 0.29–0.65; P < 0.001] in the intervention and by 85% (HR 0.15, 95% CI 0.08–0.27; P < 0.001) in the post-intervention periods. During the intervention period, VAP rates decreased by 42% (HR 0.58, 95% CI 0.38–0.87; P < 0.001) after implementation of eight preventive measures without SOD, and by 70% after adding SOD (HR 0.30, 95% CI 0.13–0.72; P < 0.001) compared to the pre-intervention period. The incidence density of intrinsically resistant bacteria (to colistin or tobramycin) did not increase. We documented a significant reduction of days of therapy per 1000 patient-days of broad-spectrum antibiotic used to treat lower respiratory tract infection (P < 0.028), median duration of MV (from 7.1 to 6.4 days; P < 0.003) and ICU mortality (from 16.2 to 13.5%; P < 0.049) for patients ventilated > 48 h between the pre- and post-intervention periods. CONCLUSIONS: Our preventive program produced a sustained decrease in VAP incidence. SOD provides an additive value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-018-5227-4) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6244525
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-62445252018-12-04 Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination Landelle, C. Nocquet Boyer, V. Abbas, M. Genevois, E. Abidi, N. Naimo, S. Raulais, R. Bouchoud, L. Boroli, F. Terrisse, H. Bosson, J.-L. Harbarth, S. Pugin, J. Intensive Care Med Original PURPOSE: We describe the impact of a multifaceted program for decreasing ventilator-associated pneumonia (VAP) after implementing nine preventive measures, including selective oropharyngeal decontamination (SOD). METHODS: We compared VAP rates during an 8-month pre-intervention period, a 12-month intervention period, and an 11-month post-intervention period in a cohort of patients who received mechanical ventilation (MV) for > 48 h. The primary objective was to assess the effect on first VAP occurrence, using a Cox cause-specific proportional hazards model. Secondary objectives included the impact on emergence of antimicrobial resistance, antibiotic consumption, duration of MV, and ICU mortality. RESULTS: Pre-intervention, intervention and post-intervention VAP rates were 24.0, 11.0 and 3.9 VAP episodes per 1000 ventilation-days, respectively. VAP rates decreased by 56% [hazard ratio (HR) 0.44, 95% CI 0.29–0.65; P < 0.001] in the intervention and by 85% (HR 0.15, 95% CI 0.08–0.27; P < 0.001) in the post-intervention periods. During the intervention period, VAP rates decreased by 42% (HR 0.58, 95% CI 0.38–0.87; P < 0.001) after implementation of eight preventive measures without SOD, and by 70% after adding SOD (HR 0.30, 95% CI 0.13–0.72; P < 0.001) compared to the pre-intervention period. The incidence density of intrinsically resistant bacteria (to colistin or tobramycin) did not increase. We documented a significant reduction of days of therapy per 1000 patient-days of broad-spectrum antibiotic used to treat lower respiratory tract infection (P < 0.028), median duration of MV (from 7.1 to 6.4 days; P < 0.003) and ICU mortality (from 16.2 to 13.5%; P < 0.049) for patients ventilated > 48 h between the pre- and post-intervention periods. CONCLUSIONS: Our preventive program produced a sustained decrease in VAP incidence. SOD provides an additive value. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00134-018-5227-4) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2018-10-21 2018 /pmc/articles/PMC6244525/ /pubmed/30343312 http://dx.doi.org/10.1007/s00134-018-5227-4 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original
Landelle, C.
Nocquet Boyer, V.
Abbas, M.
Genevois, E.
Abidi, N.
Naimo, S.
Raulais, R.
Bouchoud, L.
Boroli, F.
Terrisse, H.
Bosson, J.-L.
Harbarth, S.
Pugin, J.
Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title_full Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title_fullStr Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title_full_unstemmed Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title_short Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
title_sort impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6244525/
https://www.ncbi.nlm.nih.gov/pubmed/30343312
http://dx.doi.org/10.1007/s00134-018-5227-4
work_keys_str_mv AT landellec impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT nocquetboyerv impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT abbasm impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT genevoise impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT abidin impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT naimos impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT raulaisr impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT bouchoudl impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT borolif impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT terrisseh impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT bossonjl impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT harbarths impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination
AT puginj impactofamultifacetedpreventionprogramonventilatorassociatedpneumoniaincludingselectiveoropharyngealdecontamination